Pfizer is preparing to sweeten its offer again for Metsera, the weight-loss drug startup at the center of a bidding war that also involves Novo Nordisk
1 day ago
1
Pfizer is preparing to sweeten its connection again for Metsera, the weight-loss cause startup astatine the halfway of a bidding warfare that besides involves Novo Nordisk.
Pfizer is preparing to sweeten its offer again for Metsera, the weight-loss drug startup at the center of a bidding war that also involves Novo Nordisk